June 23 - 24 2019 Paris, France
WIN Symposium 2019 is endorsed by:
ASCO® is a registered trademark of the American Society of Clinical Oncology®. Used with permission. This is not an ASCO sponsored event.
Richard L Schilsky
MD, FACP, FSCT, FASCO
Chairman, WIN Consortium, Senior Vice President & Chief Medical Officer, American Society of Clinical Oncology (ASCO)
Vice Chairman, WIN Consortium Head, Medical Oncology Department, Vall d’Hebron Institute of Oncology President, European Society for Medical Oncology (ESMO)
Message from the WIN Consortium Chairs
We are warmly inviting you to attend the WIN 2019 symposium dedicated to Innovation and global deployment of Precision Medicine that will take place on 23-24 June, 2019 in Paris, France.
Innovation and worldwide deployment of Precision Oncology were the aspirational goals of Dr. John Mendelsohn, founder and chairman of WIN and Prof. Waun Ki Hong, special advisor to WIN for lung cancer. Their recent deaths leave us deeply saddened.
We are proud to provide leadership to the WIN Consortium as chairman and vice-chairman and are excited about the challenge and privilege to continue the work started by these two great giants in oncology.
We have gathered renowned experts across the world including Jennifer A. Doudna, co-inventor of the gene-editing technology, CRISPR/Cas9, who will present a talk on this "crack in creation" and the complex ethics of genetic manipulation. Other speakers will be Jennifer A. Ligibel, Razelle Kurzrock, Apostolia-Maria Tsimberidou, Christophe Le Tourneau, Phillip G. Febbo, Andrew Mortlock and Jean-François Martini and many others to discuss both the latest discoveries as well as the real world experience of Precision Oncology.
WIN 2019 Symposium
Join Us at Our Annual Symposium:
Listen to 30 Precision Oncology leaders from academia, industry and research organizations.
View over 70 thought provoking abstracts from like-minded professionals
Showcase your work
Engage in the open discussions and network with other professionals in oncology.